Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Topiramate in the treatment of migraine: a kainate (glutamate) receptor antagonist within the trigeminothalamic pathway.

Andreou AP, Goadsby PJ.

Cephalalgia. 2011 Oct;31(13):1343-58. doi: 10.1177/0333102411418259. Epub 2011 Sep 5.

PMID:
21893557
2.

The impact of allodynia on the efficacy of almotriptan when given early in migraine: data from the "Act when mild" study.

Díaz-Insa S, Goadsby PJ, Zanchin G, Fortea J, Falqués M, Vila C.

Int J Neurosci. 2011 Dec;121(12):655-61. doi: 10.3109/00207454.2011.605191. Epub 2011 Aug 22.

PMID:
21777163
3.

Measurement of vasoactive neuropeptides in biological materials: problems and pitfalls from 30 years of experience and novel future approaches.

Edvinsson L, Ekman R, Goadsby PJ.

Cephalalgia. 2010 Jun;30(6):761-6. Review. No abstract available.

PMID:
20925142
4.

Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan--a randomised proof-of-concept trial.

Ferrari MD, Färkkilä M, Reuter U, Pilgrim A, Davis C, Krauss M, Diener HC; European COL-144 Investigators.

Cephalalgia. 2010 Oct;30(10):1170-8. doi: 10.1177/0333102410375512. Epub 2010 Jun 15.

PMID:
20855362
5.

Distribution of 5-HT(1B), 5-HT(1D) and 5-HT(1F) receptor expression in rat trigeminal and dorsal root ganglia neurons: relevance to the selective anti-migraine effect of triptans.

Classey JD, Bartsch T, Goadsby PJ.

Brain Res. 2010 Nov 18;1361:76-85. doi: 10.1016/j.brainres.2010.09.004. Epub 2010 Sep 9.

PMID:
20833155
6.

CGRP and its receptors provide new insights into migraine pathophysiology.

Ho TW, Edvinsson L, Goadsby PJ.

Nat Rev Neurol. 2010 Oct;6(10):573-82. doi: 10.1038/nrneurol.2010.127. Epub 2010 Sep 7. Review.

PMID:
20820195
7.

Trigeminal autonomic cephalalgias: paroxysmal hemicrania, SUNCT/SUNA, and hemicrania continua.

Goadsby PJ, Cittadini E, Cohen AS.

Semin Neurol. 2010 Apr;30(2):186-91. doi: 10.1055/s-0030-1249227. Epub 2010 Mar 29. Review.

PMID:
20352588
8.

What has functional neuroimaging done for primary headache ... and for the clinical neurologist?

Sprenger T, Goadsby PJ.

J Clin Neurosci. 2010 May;17(5):547-53. doi: 10.1016/j.jocn.2009.09.030. Epub 2010 Mar 12. Review.

PMID:
20227279
9.

Glutamatergic fine tuning with ADX-10059: a novel therapeutic approach for migraine?

Marin JC, Goadsby PJ.

Expert Opin Investig Drugs. 2010 Apr;19(4):555-61. doi: 10.1517/13543781003691832. Review.

PMID:
20218930
10.

Animal models of headache: from bedside to bench and back to bedside.

Andreou AP, Summ O, Charbit AR, Romero-Reyes M, Goadsby PJ.

Expert Rev Neurother. 2010 Mar;10(3):389-411. doi: 10.1586/ern.10.16. Review.

PMID:
20187862
11.

Migraine and cardiovascular disease: systematic review and meta-analysis.

Schürks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T.

BMJ. 2009 Oct 27;339:b3914. doi: 10.1136/bmj.b3914. Review.

12.
13.

Effects of tonabersat on migraine with aura: a randomised, double-blind, placebo-controlled crossover study.

Hauge AW, Asghar MS, Schytz HW, Christensen K, Olesen J.

Lancet Neurol. 2009 Aug;8(8):718-23. doi: 10.1016/S1474-4422(09)70135-8. Epub 2009 Jun 29.

PMID:
19570717
14.

Therapeutic potential of novel glutamate receptor antagonists in migraine.

Andreou AP, Goadsby PJ.

Expert Opin Investig Drugs. 2009 Jun;18(6):789-803. doi: 10.1517/13543780902913792 . Review.

PMID:
19426123
15.

Activation of iGluR5 kainate receptors inhibits neurogenic dural vasodilatation in an animal model of trigeminovascular activation.

Andreou AP, Holland PR, Goadsby PJ.

Br J Pharmacol. 2009 Jun;157(3):464-73. doi: 10.1111/j.1476-5381.2009.00142.x. Epub 2009 Mar 20.

16.

Neurobiology of migraine.

Goadsby PJ, Charbit AR, Andreou AP, Akerman S, Holland PR.

Neuroscience. 2009 Jun 30;161(2):327-41. doi: 10.1016/j.neuroscience.2009.03.019. Epub 2009 Mar 19. Review.

PMID:
19303917
17.

Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis.

Goadsby PJ, Ferrari MD, Csanyi A, Olesen J, Mills JG; Tonabersat TON-01-05 Study Group.

Cephalalgia. 2009 Jul;29(7):742-50. doi: 10.1111/j.1468-2982.2008.01804.x. Epub 2009 Feb 13.

PMID:
19222510
18.

Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1.

Eikermann-Haerter K, Dileköz E, Kudo C, Savitz SI, Waeber C, Baum MJ, Ferrari MD, van den Maagdenberg AM, Moskowitz MA, Ayata C.

J Clin Invest. 2009 Jan;119(1):99-109. doi: 10.1172/JCI36059. Epub 2008 Dec 22.

19.

The vascular theory of migraine--a great story wrecked by the facts.

Goadsby PJ.

Brain. 2009 Jan;132(Pt 1):6-7. doi: 10.1093/brain/awn321. Epub 2008 Dec 19. Review. No abstract available.

20.

PACAP38 induces migraine-like attacks in patients with migraine without aura.

Schytz HW, Birk S, Wienecke T, Kruuse C, Olesen J, Ashina M.

Brain. 2009 Jan;132(Pt 1):16-25. doi: 10.1093/brain/awn307. Epub 2008 Dec 3.

Items per page

Supplemental Content

Write to the Help Desk